Such modifier genes have been proposed for other Mendelian disorders, such as monogenic cases of autism spectrum disorder, SCN1A-related epilepsy, and cystic fibrosis (63, 64, 65). This evidence concerns the gene SCN1A and autism spectrum disorder.